InspireMD Inc (nasdaq:NSPR) Share Price

Company Profile

Business description
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Contact
6303 Waterford District Drive
Suite 215
MiamiFL33126
USA
T: +1 888 776-6804
https://www.inspiremd.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
66

Recommended

The stocks of these high-quality growth companies look undervalued today.

Margaret Giles | 21 September 2025

Underlying secular growth stronger than we thought.

Roy Van Keulen | 21 September 2025

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.

Brian Colello, CPA | 19 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,102.10	11.70	0.13%
CAC 40	7,821.47	32.12	-0.41%
DAX 40	23,462.01	177.40	-0.75%
Dow JONES (US)	46,315.27	172.85	0.37%
FTSE 100	9,214.82	1.85	-0.02%
HKSE	26,344.14	200.96	-0.76%
NASDAQ	22,631.48	160.75	0.72%
Nikkei 225	45,493.66	447.85	0.99%
NZX 50 Index	13,141.54	90.12	-0.68%
S&P 500	6,664.36	32.40	0.49%
S&P/ASX 200	8,810.90	11.40	0.13%
SSE Composite Index	3,828.58	8.49	0.22%